siRNA, Anti-DNAJC9, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT39797WQ-LNA)

The product SIRGT39797WQ-LNA is a type of small interfering RNA (siRNA) that targets DNAJC9 gene and regulates the expression of gene. The siRNA interferes with the expression of DNAJC9 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_015190.4
Alternative Names HDJC9; JDD1; SB73
Related Diseases Epithelial Recurrent Erosion Dystrophy
Purification HPLC
Target Gene
Gene ID 23234
Uniprot ID Q8WXX5
Sub Cat Target Species Modification Scale  
SIRGT86108WQ-2OMe Dnajc9 Mouse 2ʹ-O-methyl (2'-OMe) Inquiry
SIRGT87108WQ-2F Dnajc9 Mouse 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT88108WQ-2MOE Dnajc9 Mouse 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT86108WQ-RB Dnajc9 Mouse Ribo-modified Inquiry
SIRGT37797WQ-BB DNAJC9 Human Backbone-modified Inquiry

Related Products